Five years ago, a brainstorming session among Eli Lilly and Company scientists and me turned in to Indy Science Connect, a group linking scientists in the academic and corporate communities. The gr...... Read More
The Valley of Death is a much-suffered phenomenon in the financing of early-stage, science-based startups: ideas too late for basic research funding but too early for venture or industrial financin...... Read More
As a geriatrician and neuroscientist, I am committed to protect the brain of every person including my own family. There is no health without a healthy brain. For example, Alzheimer disease and oth...... Read More
Indiana is playing a leading role in the Ag Tech revolution. Three trends are among those driving that movement; increased focus on animal wellbeing, the emergence of new technologies that recogniz...... Read More
IU School of Medicine researchers recently made news with significant scientific breakthroughs in two of the school’s research priority areas: triple negative breast cancer and Alzheimer’s disease. ... Read More
A collaborative research project led in part by the Indiana Biosciences Research Institute (IBRI) has resulted in the first description of a new monogenic disease, named, “DHPS Deficiency.” Our stu...... Read More
The mission of the Regenstrief Institute is to improve health and healthcare, locally, regionally, and around the world through innovation and applied research into a range of critical issues facin...... Read More
From the state’s earliest beginnings, research universities have contributed significantly to Indiana’s society and economy. Indiana University, Purdue University and the University of Notre Dame h...... Read More
Some of the best innovations happen in the most unexpected places. Who would have thought a building that once housed beer kegs for the Indianapolis 500 would someday become the innovation center f...... Read More
The Indiana agbiosciences have been shining brightly these last few months. And, people are doing more than simply “taking notice” – they are joining our movement. Because I know the word is still...... Read More
Our state has long been known as the Crossroads of America – a natural intersection, where east-west and north-south thoroughfares meet, and where ambitious businesspeople and innovative thinkers s...... Read More
“True humility,” according to the Urban Dictionary, “is to see there is far greater than ourselves into who we can become, who others can become, and how much more we can do and be.” This definitio...... Read More
Sometimes commercializing university intellectual property takes the form of establishing startup companies. While startup creation and support should be encouraged, there are other -- and, dependi...... Read More
As we reach the mid-point of 2018, there have been several significant, positive developments in Indiana’s life sciences industry, even during a time of uncertainty related to the current business ...... Read More
The big picture for global agriculture is a challenging one. There will be 10 billion people on the planet in 2050, and not surprisingly all those people will want to eat. The amount of arable land...... Read More
Standing under a tent on a cold late March morning on a parcel of land that will soon give rise to the first buildings at 16 Tech, I had the opportunity to share the news that 16 Tech received a $3...... Read More
What does it mean when you hear that your food is being disrupted? Innovators and entrepreneurs often use the word “disruption” to connote their meaningful quest to bring new and better ideas to th...... Read More
When you hear or read the term IoT, what comes to mind – the Internet of Things, the Indiana Office of Technology, something else, or nothing at all? All these answers are, of course, correct, depe...... Read More
Indiana is intellectually and geographically positioned to be the crossroads of American business. Just as important, our culture of collaboration among the state’s universities and with private-se...... Read More
One of the largest impediments to capital formation in the biopharmaceutical industry is regulatory uncertainty. Our products are regulated by the Food and Drug Administration (FDA). ... Read More
